ENTYVIO (Vedolizumab)

(ENTYVIO is registered trademarks Takeda Pharmaceuticals.)

 

What is ENTYVIO:

ENTYVIO is a medicine that contains the active substance Mitotane and is available as a Vial.

 

About Medicine

Name: ENTYVIO
Generic Name: Vedolizumab
Strength: 300 mg of lyophilized vedolizumab in a single-use 20 mL Vial
Company: Takeda Pharmaceuticals.
Packing: Single- Use Vial

 

In how many countries ENTYVIO is approved for marketing?

ENTYVIO is available/approved in USA and Europe. We can help you to access it in India.

 

What is ENTYVIO used for?

ENTYVIO is indicated:

Adult Ulcerative Colitis (UC)- Adult patients with moderately to severely active UC who have had an inadequate response with, lost response to, or were intolerant to a tumor necrosis factor (TNF) blocker or immunomodulator; or had an inadequate response with, were intolerant to, or demonstrated dependence on corticosteroid.

Adult Crohn’s Disease (CD)- Adult patients with moderately to severely active CD who have had an inadequate response with, lost response to, or were intolerant to a TNF blocker or immunomodulator; or had an inadequate response with, were intolerant to, or demonstrated dependence on corticosteroids.

 

How can I get ENTYVIO in India?

ENTYVIO is a prescription only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –info@theindianpharma.com

We facilitate by-

• Helping in documentation to import the medicine for personal use

• Finding Genuine and reliable source in USA, Europe and Japan

• Ensuring 100% transparency.

ENTYVIO can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of ENTYVIO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees

 

Can I get ENTYVIO even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country

The Indian Pharma (IP) can help patients in accessing/importing ENTYVIO, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your enquiry to find-

ENTYVIO in South East Asia – China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

ENTYVIO in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.

ENTYVIO in North America – Mexico.

ENTYVIO in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.

ENTYVIO in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.

ENTYVIO in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.

ENTYVIO in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.

ENTYVIO in Australia and New Zealand.

 

How is ENTYVIO used?

ENTYVIO should be administered under the guidance of specialist doctor having experience in managing cancer treatments.
Recommended dose: 300 mg infused intravenously over approximately 30 minutes at zero, two and six weeks, then every eight weeks thereafter
If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information

 

Are there any side-effects/ adverse reactions/precautions associated with treatment with ENTYVIO?

It is recommended to seek your doctor’s medical advice about side effects

 

How do I contact The Indian Pharma?

You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to info@theindianpharma.com. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.

 

What information do you need to help patient in assisting documentation for ENTYVIO import for personal use?

We will require the following documents to help in documentation for Named-Patient import

  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.

Contact Details

The Indian Pharma
905, I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120-4080562.
M: +91 9650877511

WhatsApp: +91 9650877511
QQID:- 1927411523
Skype ID: tuhinsharma

E: info@theindianpharma.com